Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma

肥胖促进的胰腺癌的化学预防和机制

基本信息

项目摘要

PROJECT SUMMARY The Program Project Grant “Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma” constitutes a highly collaborative, multidisciplinary research program designed to make a significant impact on the investigation of obesity in the development of pancreatic cancer. A detailed understanding of the biological mechanisms of action of obesity on pancreatic cancer development can form the rationale for biologically-based practices, scientifically-founded recommendations and interventional strategies in the prevention of this disease. The Program Project includes expertise from the UCLA campus and Cedars Sinai Medical Center. The Program is led by experienced pancreatic cancer researchers, who have organized investigative teams to develop highly interactive and synergistic research programs. The goal is to study the mechanisms, by which obesity promotes pancreatic cancer development and to explore interventional, cancer- preventing strategies. Innovative animal and cell culture models and novel concepts strongly supported by a wealth of preliminary data are proposed. The Projects will focus on: Adipose tissue inflammation in obesity- promoted pancreatic cancer (Project 1); Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents (Project 2); Role of the pancreatic fibro-inflammatory microenvironment in obesity- promoted pancreatic cancer (Project 3). The projects will utilize an Administrative Core (with Biostatistics Sub- Core) and a Shared Resource Core, the Animal and Cell Models Core (with Pathology Sub-Core). An External Advisory Board comprised of nationally and internationally recognized translational pancreatic cancer investigators and advocates has been assembled. The Program Project is designed for maximum integration and synergy of research and key investigators, who have been collaborating for more than 12 years so that the proposed Program can be focused on the most promising investigations with the greatest translational potential and impact.
项目概要 项目资助“肥胖促进胰腺癌的化学预防和机制” 腺癌”构成了一个高度协作的多学科研究项目,旨在使 肥胖在胰腺癌发生过程中的研究具有重大影响。详细的 了解肥胖对胰腺癌发展的生物学作用机制可以形成 基于生物学的实践、有科学依据的建议和干预策略的基本原理 在预防这种疾病方面。该计划项目包括来自加州大学洛杉矶分校校园和 Cedars 的专业知识 西奈医疗中心。该计划由经验丰富的胰腺癌研究人员领导,他们组织了 研究团队开发高度互动和协同的研究计划。目标是研究 肥胖促进胰腺癌发生的机制,并探索介入、癌症治疗 预防策略。创新的动物和细胞培养模型和新颖的概念得到了强有力的支持 提出了大量的初步数据。该项目将重点关注: 肥胖症中的脂肪组织炎症 - 促进胰腺癌(项目1);降脂和降脂等化学预防胰腺癌 抗糖尿病药物(项目2);胰腺纤维炎症微环境在肥胖中的作用 促进胰腺癌(项目 3)。这些项目将利用行政核心(以及生物统计子系统) 核心)和共享资源核心、动物和细胞模型核心(带有病理学子核心)。外部 顾问委员会由国内和国际公认的转化胰腺癌专家组成 调查人员和倡导者已经集合。该计划项目旨在实现最大程度的集成 以及研究和主要研究人员的协同作用,他们已经合作了 12 年多,以便 拟议的计划可以专注于最有前途且具有最大转化潜力的研究 和影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guido Erwin Michael Eibl其他文献

Guido Erwin Michael Eibl的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guido Erwin Michael Eibl', 18)}}的其他基金

Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
慢性压力和肥胖在胰腺癌进展中的相互作用
  • 批准号:
    10409304
  • 财政年份:
    2022
  • 资助金额:
    $ 112.28万
  • 项目类别:
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
慢性压力和肥胖在胰腺癌进展中的相互作用
  • 批准号:
    10612088
  • 财政年份:
    2022
  • 资助金额:
    $ 112.28万
  • 项目类别:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
肥胖促进的胰腺癌的化学预防和机制
  • 批准号:
    10398844
  • 财政年份:
    2020
  • 资助金额:
    $ 112.28万
  • 项目类别:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
项目1:肥胖促进的胰腺癌中的脂肪组织炎症
  • 批准号:
    10398845
  • 财政年份:
    2020
  • 资助金额:
    $ 112.28万
  • 项目类别:
Core 1: Animal and Cell Model Core
核心1:动物和细胞模型核心
  • 批准号:
    10605252
  • 财政年份:
    2020
  • 资助金额:
    $ 112.28万
  • 项目类别:
Core 1: Animal and Cell Model Core
核心1:动物和细胞模型核心
  • 批准号:
    10398850
  • 财政年份:
    2020
  • 资助金额:
    $ 112.28万
  • 项目类别:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
项目1:肥胖促进的胰腺癌中的脂肪组织炎症
  • 批准号:
    10605225
  • 财政年份:
    2020
  • 资助金额:
    $ 112.28万
  • 项目类别:
Animal Core
动物核心
  • 批准号:
    8561432
  • 财政年份:
    2013
  • 资助金额:
    $ 112.28万
  • 项目类别:
Inflammatory processes In diet-Induced pancreatic cancer promotion
饮食诱发的胰腺癌促进中的炎症过程
  • 批准号:
    8561427
  • 财政年份:
    2013
  • 资助金额:
    $ 112.28万
  • 项目类别:
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
针对饮食诱导的 Kras 引发的胰腺癌的促进作用
  • 批准号:
    8337028
  • 财政年份:
    2012
  • 资助金额:
    $ 112.28万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 112.28万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 112.28万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 112.28万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 112.28万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 112.28万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 112.28万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 112.28万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 112.28万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 112.28万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 112.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了